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Excessive alcohol intake is a major public health challenge worldwide 
and has been identified as one of the main determinants of a variety
of non-communicable diseases [1]. The World Health Organization 
(WHO) estimates that 4.5% of the global burden of disease and injury, 
and 4% of all deaths worldwide are attributable to alcohol [2]. Alcohol 
is the leading risk factor for death among males aged 15–59 years, 
particularly in Eastern Europe [2,3].
   Toxic and other adverse effects of alcohol on organs and tissues in
humans (see Figure) are largely a consequence of its metabolism to 
acetaldehyde, and associated formation of reactive oxygen and nitro-
gen species, depletion of co-factors (e.g., NAD+), and impairment in 
energy homeostasis [4]. Because of the considerable redundancy in 
the oxidative enzymatic pathways (alcohol dehydrogenases, CYP2E1, 
and catalase) that can convert alcohol to acetaldehyde, most tissues 
are capable of alcohol metabolism, even though the liver is the primary 
site. Likewise, acetaldehyde dehydrogenases are ubiquitous in the mi-
tochondria. A minor, non-oxidative, pathway of alcohol metabolism is 
to fatty acid ethyl ester (via fatty acid ethyl ester synthase) and phos-
phatidyl ethanol (via phospholipase D). Alcohol impacts the integrity of 
the gastrointestinal mucosal barrier. This results in the translocation, 
via the portal blood flow, of the gut bacteria-derived lipopolysaccharide
(endotoxin) and other molecules to the liver, and activation of the innate 
immune response.
   The molecular and cellular sequelae of the toxic mediators of alcoholic 
injury take many forms. Acetaldehyde and oxidants are highly reactive 
molecules that can damage DNA, proteins, and lipids. Changes in he-
patic respiration and lipid metabolism lead to tissue hypoxia and impair-
ment in the mitochondrial function. Secondary effects include disruption 
of signaling pathways and ion channel function, unfolded-protein re-
sponse, and oxidative stress, as well as activation of adaptive immune
response largely triggered by acetaldehyde-protein adducts. Cell death
triggers additional innate immune response, activation of fibrogenesis,
and tissue repair. In addition to pro-inflammatory mediators, other sign-
aling molecules, such as neurotransmitters, are affected by alcohol.
Gross pathological changes associated with alcohol drinking include
most or all, depending on the affected tissue, of the following: fat ac-
cumulation (steatosis), inflammation, necrosis, and fibrosis [5]. Impair-
ment of organ function and carcinogenesis are most advanced patho-
logical effects and are associated with organ dysfunction and increased 
mortality. As a consequence, alcoholic beverages and ethanol in alco-
holic beverages are classified by the WHO International Agency for Re-
search on Cancer as “carcinogenic to humans” (Group 1) [6].
   Alcohol is highly diffusible through cell membranes and is metabolized
by most tissues. Thus, its toxicity affects most organs. Because the liver 
is the major site of alcohol metabolism, it is one of the major targets for 
alcohol-induced organ damage. Alcoholic liver diseases include steato-
sis, different subtypes of steatohepatitis, cirrhosis, and hepatocellular 
carcinoma [5]. Of these, cirrhosis of the liver is the third leading (at 
16.6%) cause of alcohol-attributable deaths worldwide [2]. In addition, 
other anatomical sites in the aero-digestive tract are adversely affected
by alcohol, with most important morbidity and mortality due to malignant 
tumors, all causally related to alcohol consumption, of the oral cavity, 
pharynx, larynx, esophagus, and colorectum [6]. In the pancreas, toxic
metabolites of alcohol cause acinar cell injury leading to pancreatitis 
and subsequent fibrosis [7]. The cardiovascular system is second only 
to gastrointestinal organs in toxic effects of alcohol [1,2]. Hypertension, 
ischemic heart disease, stroke, cardiomyopathy, and myocarditis, as
well as various arrhythmias, have been associated with alcohol abuse. 
The linkages between alcohol use and neuropsychiatric disorders have 
also been established as causal (e.g., for major depression) [8]. In addi-
tion, neurobehavioral impairment due to alcohol intoxication is a major 
contributor to deaths from violence, road traffic accidents, and injuries
[2]. In the kidney, excessive alcohol intake has been associated with 
IgA glomerulonephritis, acute nephropathy, and kidney graft failure [9]. 
Adverse effects of alcohol on human reproduction and development 
span the wide range of pathological conditions from impaired fertility to
premature and low-weigh births, and fetal alcohol syndrome spectrum
disorders [2]. The addition of breast cancer to the list of cancers caus-
ally related to alcohol consumption suggested that the proportion of ma-
lignancies attributable to alcohol consumption is higher than previously 
estimated [6]. Indeed, recent studies show that up to 5% of breast can-
cers are attributable to alcohol in northern Europe and North America 
for a total of approximately 50,000 alcohol-attributable cases of breast 
cancer worldwide [10].
   Factors affecting susceptibility to alcohol toxicity include genetics, 
gender, lifestyle/nutrition, exposure to environmental chemicals and 
drugs, and co-morbidities. Variations in genes encoding metabolic 
pathways for alcohol or triglycerides, as well as many other genes that 
may be involved in the pathogenesis or protection from alcohol-induced
toxicity, modify the individual’s response to alcohol abuse and disease 
outcomes [4–6]. The effect of gender varies by disease outcome with
females being more susceptible to alcoholic liver disease, but most 
alcohol-attributable deaths occur in males [1,2]. Dietary (e.g., high-fat 
consumption, patterns of alcohol intake), life style (e.g., cigarette smok-
ing, drugs of abuse), and environmental (e.g., nitrosamines, metals,
and chlorinated solvents) factors also affect both morbidity and mortal-
ity related to alcohol abuse. Obesity, viral infections, iron accumulation, 
and other pro-inflammatory conditions, as well as concomitant use of 
certain drugs (e.g., acetaminophen, isoniazid, and methotrexate), also
compound morbidity and mortality due to alcohol abuse.
   Finally, while overwhelming evidence exists to conclude that con-
sumption of alcoholic beverages is harmful to human health, many stud-
ies observed some beneficial effects of modest alcohol consumption 
(usually defined as 1–2 servings/day) [1]. Health conditions that have
been associated with “beneficial effects” of alcohol on mortality include
cardiovascular diseases (e.g., myocardial infarction) and chronic kidney 
disease [1,9], yet such protection disappears with heavy drinking occa-
sions [2]. No “safe” amount of alcohol consumption has been found for 
cancer; even consumption of two drinks per day causes a significant 
increase in risk [6].
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Fig. Layered graph showing the mechanisms of alcohol-induced toxicity and organ damage. Layer #1: the amount of alcohol intake is a main determinant of toxicity. Layer #2: alcohol 
metabolism is regulated by several enzymes and is a major determinant of alcohol-induced toxicity. Genetic variations and expression of these enzymes regulate systemic and local effects 
of alcohol intake. Layer #3: alcohol metabolites and molecules released in damaged organs, such as acetaldehyde and ROS, are key toxicity mediators with powerful biological properties. 
Layer #4: such mediators activate several cellular and molecular mechanisms, such as disrupted lipid metabolism, hypoxia, ER stress, dysregulated immunity, changes in intestinal 
microbiota and DNA damage. Layer #5: the synergistic effect of the activation of these pathways leads to different histological disturbances in target tissues, such as fat accumulation, 
inflammation (PMN cells), necrosis/apoptosis, fibrosis and cancer, leading to organ dysfunction. Layer #6: the most susceptible organs to the deleterious effects of alcohol, that account 
for most of clinical complications, include normal development of the fetus, liver, kidney, nervous system, aero-digestive tract, reproductive system, pancreas, and cardiovascular system. 
Layer #7: the individual susceptibility to the toxic effects of alcohol in the human body is determined by genetic (gender, SNPs in target genes such as PNPLA3), dietary, and environmental 
exposures. Finally, patients with co-morbidities, such as viral infections or metabolic disorders, are more susceptible to the deleterious effects of alcohol abuse. EtOH, ethanol; ADH, alcohol 
dehydrogenase; ALDH, acetaldehyde dehydrogenase; ER, endoplasmic reticulum; PNPLA3, patatin-like phospholipase domain-containing protein 3; SNPs, single nucleotide polymorphism.
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